Valuation : GKB Ophthalmics Limited

Market Cap 33Cr 35.03L 30.14L 28.38L 25.86L 48.39L 48.58L 3.36Cr 1.3Cr 17Cr 1.32Cr 1.29Cr 54Cr P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 41Cr 42.64L 36.69L 34.55L 31.48L 58.89L 59.13L 4.09Cr 1.58Cr 21Cr 1.6Cr 1.57Cr 65Cr EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
12/08 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
27/05 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/25/15 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/25/13 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/24/14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/24/13 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/24/30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/24/19 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/24/14 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/23/14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day-9.99%
1 week+5.50%
Current month+3.33%
1 month+13.26%
3 months+10.12%
6 months+17.61%
Current year+29.06%
1 week 62.4
Extreme 62.4
73.7
1 month 58.39
Extreme 58.39
73.7
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
78.15
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 58 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-9.99%+5.50%-7.46%-35.86% 39.06L
-0.40%-6.11%-42.69%-14.49% 8TCr
+0.14%-5.83%-11.33%-24.38% 3.34TCr
-2.23%-4.09%-2.01%-23.91% 1.32TCr
-0.27%+4.54% - - 1.28TCr
+0.50%+3.52%-1.03%+629.59% 271.14Cr
-1.90%-2.95%-40.70%-58.23% 147.4Cr
-4.29%-2.12% - - 97Cr
-0.80%-5.93%+14.24%+1.77% 92Cr
-1.70%-5.28%-38.71%-22.62% 88Cr
Average -2.05%+1.43%-16.21%+56.48% 1.46TCr
Weighted average by Cap. -0.47%-4.10%-29.45%-5.17%

Financials

2025 2026
Net sales 108.99Cr 1.15Cr 98.56L 92.8L 84.56L 1.58Cr 1.59Cr 11Cr 4.25Cr 56Cr 4.3Cr 4.21Cr 175.9Cr 149.06Cr 1.57Cr 1.35Cr 1.27Cr 1.16Cr 2.16Cr 2.17Cr 15Cr 5.81Cr 76Cr 5.88Cr 5.75Cr 240.58Cr
Net income -7.04Cr -7L -6L -6L -5L -10.23L -10.27L -71.09L -27.48L -3.59Cr -27.8L -27.2L -11Cr 1.22Cr 1L 1L 1L 94.54T 2L 2L 12.3L 5L 62.08L 5L 5L 1.97Cr
Net Debt 1.56Cr 2L 1L 1L 1L 2L 2L 15.73L 6L 79.43L 6L 6L 2.52Cr 7.24Cr 8L 7L 6L 6L 10.51L 10.55L 73.05L 28.23L 3.69Cr 28.56L 27.94L 12Cr
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
09/26/09 66.13 -9.99% 7,176
08/26/08 ₹73.47 +9.66% 12,225
07/26/07 ₹67.00 +3.14% 889
04/26/04 ₹64.96 +3.05% 2,747
02/26/02 ₹63.04 +0.57% 1,360
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!